Samsung BioLogics Co., Ltd. is a leading pharmaceutical company based in South Korea with a low risk ESG score of 16.9. Specializing in the development and manufacturing of bio-healthcare products, the company's services include Process Development, cGMP Manufacturing, and Aseptic Fill and Finish.